A detailed history of Marshall Wace, LLP transactions in In Mode Ltd. stock. As of the latest transaction made, Marshall Wace, LLP holds 59,183 shares of INMD stock, worth $1.1 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
59,183
Previous 50,300 17.66%
Holding current value
$1.1 Million
Previous $917,000 9.16%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$15.43 - $19.06 $137,064 - $169,309
8,883 Added 17.66%
59,183 $1 Million
Q2 2024

Aug 14, 2024

SELL
$17.02 - $21.0 $391,953 - $483,609
-23,029 Reduced 31.41%
50,300 $917,000
Q1 2024

May 15, 2024

BUY
$20.45 - $26.49 $151,923 - $196,794
7,429 Added 11.27%
73,329 $1.58 Million
Q4 2023

Feb 14, 2024

BUY
$19.02 - $30.13 $1.25 Million - $1.99 Million
65,900 New
65,900 $1.47 Million
Q2 2022

Aug 15, 2022

SELL
$20.97 - $37.47 $137,647 - $245,953
-6,564 Closed
0 $0
Q1 2022

May 16, 2022

BUY
$34.38 - $65.77 $225,670 - $431,714
6,564 New
6,564 $242,000
Q4 2021

Feb 14, 2022

SELL
$63.78 - $97.86 $10.5 Million - $16.1 Million
-164,426 Closed
0 $0
Q3 2021

Nov 15, 2021

BUY
$45.58 - $88.24 $5.19 Million - $10 Million
113,845 Added 225.07%
164,426 $26.2 Million
Q2 2021

Aug 13, 2021

BUY
$34.4 - $48.34 $1.17 Million - $1.64 Million
33,929 Added 203.75%
50,581 $4.79 Million
Q1 2021

May 17, 2021

BUY
$23.17 - $38.3 $385,826 - $637,771
16,652 New
16,652 $1.21 Million
Q3 2020

Nov 16, 2020

SELL
$12.91 - $18.51 $831,558 - $1.19 Million
-64,412 Closed
0 $0
Q2 2020

Aug 13, 2020

BUY
$9.68 - $17.5 $236,598 - $427,735
24,442 Added 61.15%
64,412 $1.82 Million
Q1 2020

May 15, 2020

BUY
$7.43 - $24.88 $296,977 - $994,453
39,970 New
39,970 $860,000

Others Institutions Holding INMD

About InMode Ltd.


  • Ticker INMD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 83,081,104
  • Market Cap $1.55B
  • Description
  • InMode Ltd. designs, develops, manufactures, and markets minimally invasive aesthetic medical products based on its proprietary radiofrequency assisted lipolysis and deep subdermal fractional radiofrequency technologies in the United States and internationally. The company offers minimally invasive aesthetic medical products for various procedur...
More about INMD
Track This Portfolio

Track Marshall Wace, LLP Portfolio

Follow Marshall Wace, LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Marshall Wace, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Marshall Wace, LLP with notifications on news.